A 79-Year-Old Man With Relapsed Chronic Lymphocytic Leukemia

Video

Jeff Sharman, MD, reviews a case of a 79-year-old man with relapsed chronic lymphocytic leukemia.

Case: A 79-Year-Old Man With Relapsed Chronic Lymphocytic Leukemia

Initial presentation

  • A 79-year-old man presented to a new medical oncologist for the first time complaining of vague intermitted abdominal pain, and progressive fatigue
  • PMH:
    • Hypertension, medically controlled
    • MI, 8 years ago, on 81 mg aspirin
    • CLL, diagnosed 7 years ago
    • After a period of watchful waiting he began treatment with ibrutinib 420 mg PO qDay; symptoms improved and achieved stable disease, resolution of lymphadenopathy
    • After 5 years of disease control on ibrutinib he complained of increasing fatigue and decreased appetite, on physical exam there was return of palpable lymphadenopathy; spleen was palpable ~4 cm below costal margin
    • He was started on rituximab
    • Currently after 6 months on rituximab monotherapy he presents to the clinic
  • PE: palpable bilateral cervical and right-sided inguinal lymphadenopathy

Clinical workup

  • Labs: WBC 55,000, lymphocyte 82%, ANC 3100/mm3, Hb 9.4 g/dL, plt 90 x 109/L, LDH 220 U/L, Beta-2-microglobulin 3.9 mg/L; creatinine clearance 31 mL/min
  • FC CD 5+, CD19+, CD20+ monoclonal B-cell population
  • FISH: CLL probe set tested, deletion 17p
  • IgHV mutational status: unmutated
  • Rai stage IV; ECOG PS 1
  • Treatment of idelalisib 150 mg PO BID was added to rituximab
Related Videos
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Related Content